Skip to main content
Robert Orenstein, DO, Infectious Disease, Phoenix, AZ

RobertOrensteinDOFIDSA, FACP

Infectious Disease Phoenix, AZ

HIV/AIDS Medicine, Healthcare Associated Infections, Transplant/Immunocompromised States, International Health, Travel & Tropical

Chair Infectious Diseases Department of Medicine Mayo Clinic Arizona Professor of Medicine, Mayo Clinic College of Medicine and Science

Dr. Orenstein is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Orenstein's full profile

Already have an account?

  • Office

    5777 E. Mayo Boulevard
    Phoenix, AZ 85050

Summary

  • I am a board certified Infectious Diseases specialist with expertise in the prevention and management of complex infections My research focuses on prevention and management of Clostridiodes difficile infections.

Education & Training

  • Virginia Commonwealth University
    Virginia Commonwealth University1991 - 1993
  • Geisinger Health System (Danville)
    Geisinger Health System (Danville)Residency, Internal Medicine, 1988 - 1991
  • Botsford General Hospital
    Botsford General HospitalInternship, 1987 - 1988
  • Des Moines University College of Osteopathic Medicine
    Des Moines University College of Osteopathic MedicineClass of 1987, D.O., Sigma Sigma Phi
  • Trinity College
    Trinity CollegeBS, Biochemistry , 1977 - 1981

Certifications & Licensure

  • AZ State Medical License
    AZ State License 2010 - 2025
  • MN State Medical License
    MN State License 2002 - 2025
  • VA State Medical License
    VA State License 1991 - 2008
  • PA State Medical License
    PA State License 1989 - 2002
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Infectious Disease
  • American Academy of HIV MedicineHIV

Awards, Honors, & Recognition

  • Above and Beyond Clinician Award Mayo Clinic Arizona, Dept of Medicine, 2021
  • Senior Fellow Academy of Academic Excellence- Mayo Clinic, 2020
  • Academy Award American Academy of Osteopathy, 2019
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • TNF-Inhibitors and Infection.  
    Orenstein R, Matteson EL, Infect Med 2006; 23:99-114
  • Infections related to TNF-Inhibitors.  
    Orenstein R, Expert Rev Dermatol 2006; 1(5): 757-769
  • Opportunistic Infections associated with TNF-alpha Treatment.  
    Orenstein R, Matteson EL, Future Rheumatol 2007;2:567-576
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • Staged Approach to the reduction of C. difficile infection.
    Orenstein R, Thompson RL, Rosenblad M, Patel R, Annual Meeting of the Society for Healthcare Epidemiology of America, San Diego, CA
  • Sustained Elimination of C. difficile Infection.
    Orenstein R, Fedraw L. Aronhalt K, McManus J, Link M, Annual Scientific Meeting of the Society for Healthcare Epidemiology of America, Dallas, TX
  • A simple pre-operative prediction tool for surgical site infection in vascular surgery.
    Leekha S, Thompson RL, Sampathkumar P, Lahr B, Duncan A, Orenstein R, 5th Decennial International Conference on Healthcare Associated Infections, SHEA, CDC, APIC, IDSA, Atlanta, Georgia
  • Join now to see all

Lectures

  • Multiple Small Feedings of the Mind, Infectious Diseases. 
    American College of Physicians Annual Meeting
  • How to use antibiotics effectively in the outpatient arena. 
    Primary Care Grand Rounds, McGuire VA Medical Center, Richmond, VA
  • HIV in the Elderly. 
    Division of Geriatrics Grand Rounds, Hunter Holmes McGuire VA Medical Center, Richmond, VA
  • Join now to see all

Press Mentions

  • Stopping the Cycle of C. Diff
    Stopping the Cycle of C. DiffFebruary 8th, 2023
  • Ferring to Present Analyses for Investigational Microbiota-Based Live Biotherapeutic RBX2660 in Patients with Recurrent C. Difficile Infection at ACG 2022
    Ferring to Present Analyses for Investigational Microbiota-Based Live Biotherapeutic RBX2660 in Patients with Recurrent C. Difficile Infection at ACG 2022October 11th, 2022
  • “All About the Mission”
    “All About the Mission”August 1st, 2022
  • Join now to see all

Professional Memberships